cf

(redirected from fibrosis)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to fibrosis: Pulmonary fibrosis, Liver fibrosis

CF

The two-character ISO 3166 country code for CENTRAL AFRICAN REPUBLIC.

Cf

1. On a bond transaction table, an abbreviation indicating that a bond has matured, but is still trading.

2. ISO 3166-1 alpha-2 code for the Central African Republic. This is the code used in international transactions to and from Central African bank accounts.

3. ISO 3166-2 geocode for the Central African Republic. This is used as an international standard for shipping to the Central African Republic. The capital and each prefecture have their own codes with the prefix "CF." For example, the code for the Prefecture of Ouaka is ISO 3166-2:CF-UK.

cf

Used in bond transaction tables in newspapers to indicate that the certificate of a bond has matured but is still trading: VarCp 10s99cf.
References in periodicals archive ?
Fibrosis progression rates are higher in HIV-HCV coinfected than in non-HIV patients, in both SVR and not treated; SVR was associated with a slower regression of fibrosis and a worrisome remaining risk of HCC, higher than in HCV monoinfected patients (J Hepatol 2014).
Idiopathic pulmonary fibrosis is a condition in which, over a period of time, lung tissue becomes thickened, stiff and scarred.
6 The evaluation of magnitude of liver fibrosis is vital in the management of patients with chronic hepatitis.
After adjusting for known predictors of fibrosis, the risk for greater fibrosis severity in post-menopausal women and men vs.
This protein is normally present in the body in an inactive state and must be turned on to cause fibrosis.
Walgreens has a long-standing relationship with the cystic fibrosis community, and we understand the unique needs and challenges that CF patients and their families face," Walgreens vice president of specialty pharmacy and infusion Mike Ellis said when the agreement with the Cystic Fibrosis Foundation was announced.
Cystic Fibrosis is one of the UK's most common inherited conditions, affecting over 9,000 babies, children and adults.
Consider respiratory therapies such as tobramycin, hypertonic saline, and recombinant human DNase in cystic fibrosis patients with relatively mild or atypical disease.
With the genetic modifications, the researchers hope they will be able to mimic the lung disease that afflicts humans who have cystic fibrosis.
In the last 25 years, 35 reviews and 25 editorials of noninvasive fibrosis markers have been identified (see Appendix in the Data Supplement that accompanies the online version of this article at http://www.
The FDA and European Medicines Agency have both previously granted Bronchitol orphan drug status for treating cystic fibrosis.